Medtech Startup Strategy Assessment

Early Regulatory and Market Strategy for Startups Preparing to Enter the US and Europe

Many promising medtech startups secure early funding based on strong technology. As they advance in their development, however, early decisions about regulatory and market strategy can have a lasting impact on development timelines, fundraising, and market entry.

Alira Health’s Medtech Startup Strategy Assessment is a strategic evaluation designed for early-stage medtech companies preparing to enter the US and European markets.

The assessment provides practical, cost-effective guidance to validate your regulatory and market strategy, identify key development risks and milestones, and strengthen your commercialization roadmap before making major development and fundraising decisions.

A Straightforward Three-Step Process

Situation analysis

We review your main information available and your objectives, aspirations, and potential needs. We also study your product’s characteristics, target indication, intended users, and other relevant details that impact regulatory requirements.

After this review, we define the scope of the assignment to carry out.

Strategic assessment

Our experts analyze your product against current regulatory frameworks and commercialization requirements. We then conduct a 30-minute meeting with your team to go through the main outcomes of the documents analyzed.

Actionable report

Within approximately 3–4 weeks, you receive a concise report with practical recommendations, followed by a review session with our experts.

1. Situation analysis

After this review, we define the scope of the assignment to carry out.

2. Regulatory assessment

3. Actionable report

Within approximately 3–4 weeks, you receive a concise report with practical recommendations, followed by a review session with our experts.

What's Included in the Assessment

The assessment is tailored to your product and business objectives. Examples of topics that our assessment touch upon:

Appropriate product classification for your intended markets
Your intended use and potential regulatory implications
Identification of the most suitable US and European regulatory pathways
Regulations and guidance applicable to your product
Early clinical evidence requirements and development considerations
Key regulatory risks and practical mitigation strategies
Benchmark of your product against the current competitive landscape
Early reimbursement codes and potential challenges
Your investor story improvement by challenging key assumptions in your pitch deck

Why Startups Value This Assessment

This program provides quick, focused, and practical guidance at the early stage when strategic decisions have the greatest impact. Alira Health’s Medtech Startup Strategy Assessment can help you:

Meet With Our Team at MedTech World Asia

Are you preparing for your next investment round or defining your regulatory strategy? Meet our team to learn how we can help.

Mercè Guerra

Associate Director,
Regulatory Affairs Medtech

Tabatha Bourgois

Business Development Director, Regulatory Affairs Medtech

About Alira Health

Alira Health has extensive experience supporting healthcare startups in progression from early-stage innovation to successful commercialization and sustainable growth.

We understand the unique challenges faced by emerging companies, like defining regulatory pathways, generating clinical evidence, securing market access, and preparing for launch.

Beyond the expertise included within this program, Alira Health offers access to a broad network of disciplines that span regulatory affairs, clinical development, biometrics, market access, patient engagement, and commercial strategy. As a trusted end-to-end partner, we can provide additional specialized support as companies evolve and their needs grow, ensuring continuity throughout the entire product lifecycle.